@article{ref1,
title="Non-hematologic adverse effects related to interferon therapy in patients with chronic HCV hepatitis",
journal="Therapeutics, Pharmacology and Clinical Toxicology",
year="2012",
author="Cristina, P. and Victoria, A.",
volume="16",
number="2",
pages="77-84",
abstract="Pegylated interferon and ribavirin are mandatory in the treatment of HCV hepatitis. An earlyrecognition of side effects related to the antiviral therapy can prevent the discontinuation of treatment andcan improve the eradication of HCV infection. Hematologic side effects related to pegylated interferonand ribavirin therapy are the most studied; on the other hand it is difficult to make a correlation betweena rarely reported side effect and the medication. That's why it is important to report and to recognizeall these side effects in order to avoid life-threatening. This review analyses non-hematologic side effectscorrelated with antiviral therapy for HCV hepatitis. © Copyright reserved 2012.<p /><p>Language: en</p>",
language="en",
issn="1583-0012",
doi="",
url="http://dx.doi.org/"
}